Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
WORLD / Science & Health
May 14, 2020
France says ‘unacceptable’ for U.S. to get Sanofi vaccine first
Giving the U.S. priority access to a Sanofi vaccine against the new coronavirus would be "unacceptable,” a French government minister said.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.
Japan Times
JAPAN / FOCUS
May 12, 2020
Abe follows Trump's example, approving drugs quickly after criticism
Japanese regulators are usually known for taking a year to approve new drugs, but authorized remdesivir just three days after receiving the application.
Japan Times
WORLD / Science & Health
May 2, 2020
U.S. emergency approval broadens use of Gilead's COVID-19 drug remdesivir
Gilead Science Inc.'s antiviral drug remdesivir was granted emergency use authorization by the U.S. Food and Drug Administration for COVID-19 on Friday, clearing the way for broader use of the drug in more hospitals around the United States.
Japan Times
WORLD / Science & Health
May 1, 2020
Virus drugmaker caught between making a profit and treating the world
Gilead Sciences Inc. may spend $1 billion on its breakthrough new treatment for COVID-19 this year alone, Chief Executive Officer Daniel O’Day said. How much revenue — if any — the company expects to generate is another matter.
Japan Times
WORLD / Science & Health
Apr 26, 2020
Countries and companies risk billions in race for coronavirus vaccine
Governments, charities and Big Pharma firms are making huge bets with extraordinarily low odds of success.
Japan Times
WORLD
Apr 23, 2020
Official says he was ousted for urging caution on Trump-touted virus drug
The ousted director of a key U.S. agency charged with developing drugs to fight the COVID-19 pandemic said Wednesday he was dismissed because he called for careful vetting of a treatment frequently touted by President Donald Trump.
Japan Times
WORLD / Science & Health
Apr 22, 2020
Hydroxychloroquine, championed by Trump for virus, may raise death risk
An old malaria drug touted by U.S. President Donald Trump as a "game changer" in the fight against the coronavirus provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that has been submitted for expert review.
BUSINESS / Companies
Apr 15, 2020
Fujifilm to boost capacity to make COVID-19 treatment Avigan
Fujifilm Holdings Corp. said Wednesday it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19.
Japan Times
WORLD / Science & Health
Apr 14, 2020
Coronavirus drug hopefuls are cheap to make but may quickly be in short supply
Drugs being repurposed in hopes they will help against COVID-19 cost relatively little to make but may prove challenging to produce in quantities needed for a pandemic, a drug pricing expert has said.
Japan Times
ASIA PACIFIC / Science & Health
Apr 7, 2020
After Trump threat, India lifts export ban on COVID-19 treatment drug
India has partially lifted a ban on the exports of a malaria drug after U.S. President Donald Trump sought supplies for the United States, according to government officials with knowledge of the matter.
Japan Times
WORLD / Science & Health / FOCUS
Apr 6, 2020
Fast-moving virus pits treating patients against finding a cure
Pharmaceutical research experts are raising concerns that attempts to offer desperate coronavirus patients some form of treatment may hobble crucial studies of which drugs actually work and which ones don't.

Longform

Professional cleaner Hirofumi Sakurai takes a moment to appreciate some photographs in a Gotanda apartment whose occupant died alone.
The last cleanup: Life and death in a lonely Japan